Kelley Shannon T

General CounselMADRIGAL PHARMACEUTICALS, INC. (MDGL) · full profile →Form 4 · filed Jan 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$344K
Net Open-Market Flow
-$344K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 20, 2026Sell(S)429$501.40$215K8K
Jan 20, 2026Sell(S)263$490.77$129K9K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-002742) within minutes of acceptance. Every field above traces to the original document. Verify it directly: